JP2011502141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011502141A5 JP2011502141A5 JP2010531646A JP2010531646A JP2011502141A5 JP 2011502141 A5 JP2011502141 A5 JP 2011502141A5 JP 2010531646 A JP2010531646 A JP 2010531646A JP 2010531646 A JP2010531646 A JP 2010531646A JP 2011502141 A5 JP2011502141 A5 JP 2011502141A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- quinazoline
- substituted
- tetrazol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 **1CCCC1 Chemical compound **1CCCC1 0.000 description 6
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2445CH2007 | 2007-10-29 | ||
| PCT/IN2008/000708 WO2009057139A2 (en) | 2007-10-29 | 2008-10-28 | Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011502141A JP2011502141A (ja) | 2011-01-20 |
| JP2011502141A5 true JP2011502141A5 (enExample) | 2011-12-15 |
Family
ID=40433677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010531646A Pending JP2011502141A (ja) | 2007-10-29 | 2008-10-28 | 抗癌剤としての４‐（テトラゾール‐５‐イル）‐キナゾリン誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8080558B2 (enExample) |
| EP (1) | EP2220054A2 (enExample) |
| JP (1) | JP2011502141A (enExample) |
| KR (1) | KR20100087185A (enExample) |
| CN (1) | CN101878203A (enExample) |
| AU (1) | AU2008320342B2 (enExample) |
| CA (1) | CA2703767A1 (enExample) |
| EA (1) | EA018716B1 (enExample) |
| GE (1) | GEP20125603B (enExample) |
| MX (1) | MX2010004625A (enExample) |
| MY (1) | MY150054A (enExample) |
| NZ (1) | NZ585357A (enExample) |
| UA (1) | UA101168C2 (enExample) |
| WO (1) | WO2009057139A2 (enExample) |
| ZA (1) | ZA201002807B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103130729B (zh) * | 2011-12-05 | 2015-07-15 | 齐鲁制药有限公司 | 一种4-氯代-7-甲氧基喹唑啉-6-醇乙酸酯的制备方法 |
| WO2014039714A2 (en) * | 2012-09-06 | 2014-03-13 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| CN102993114B (zh) * | 2012-10-11 | 2015-08-12 | 南通市华峰化工有限责任公司 | 一种1h-四唑-5-乙酸的生产方法 |
| CN103204817B (zh) * | 2013-04-16 | 2018-03-27 | 江西师范大学 | 4‑氰基喹唑啉衍生物的制备方法 |
| DE102013008118A1 (de) * | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
| JP6704422B2 (ja) | 2015-03-20 | 2020-06-03 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッドChia Tai Tianqing Pharmaceutical Group Co., Ltd. | キナゾリン誘導体の塩およびその製造方法 |
| CN114787151B (zh) * | 2019-11-01 | 2024-04-16 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物或其盐、或其药物组合物的用途 |
| JP2023549973A (ja) * | 2020-11-23 | 2023-11-29 | エフ． ホフマン－ラ ロシュ アーゲー | テトラゾール誘導体の製造のための新規方法 |
| CN114437041B (zh) * | 2022-02-25 | 2023-11-10 | 湖北科技学院 | 一类具有抗肿瘤活性的4-四唑基取代-3，4-二氢喹唑啉衍生物及其制备方法和应用 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3800039A (en) * | 1970-10-21 | 1974-03-26 | Mead Johnson & Co | Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines |
| JPH078851B2 (ja) | 1985-07-29 | 1995-02-01 | 鐘淵化学工業株式会社 | ３−フエニルチオメチルスチレン誘導体 |
| DE3874257T2 (de) | 1987-03-11 | 1993-02-11 | Kanegafuchi Chemical Ind | Hydroxystyren-derivate. |
| AU632992B2 (en) | 1987-12-24 | 1993-01-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation |
| DE3917982A1 (de) | 1989-06-02 | 1990-12-06 | Behringwerke Ag | Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen |
| AU658646B2 (en) | 1991-05-10 | 1995-04-27 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
| PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
| GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
| GB9323290D0 (en) | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
| GB9314893D0 (en) * | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
| GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| TW321649B (enExample) | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| GB9424233D0 (en) | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
| DE69536015D1 (de) | 1995-03-30 | 2009-12-10 | Pfizer Prod Inc | Chinazolinone Derivate |
| WO1996033977A1 (en) | 1995-04-27 | 1996-10-31 | Zeneca Limited | Quinazoline derivatives |
| GB9508537D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9508535D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivative |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| GB9508565D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
| US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
| GB9514265D0 (en) | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
| AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| SK284073B6 (sk) | 1996-04-12 | 2004-09-08 | Warner-Lambert Company | Polycyklické zlúčeniny, ich použitie a farmaceutické kompozície na ich báze |
| EP0912559B1 (en) | 1996-07-13 | 2002-11-06 | Glaxo Group Limited | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
| HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
| DE69718472T2 (de) | 1996-07-13 | 2003-11-06 | Glaxo Group Ltd., Greenford | Bicyclische heteroaromatische verbindungen als protein tyrosine kinase inhibitoren |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9800569D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| GB9800575D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
| CZ20021009A3 (cs) | 1999-09-21 | 2002-06-12 | Astrazeneca Ab | Deriváty chinazolinu, způsob jejich přípravy a jejich pouľití jako léčiv |
| GB0002040D0 (en) | 2000-01-28 | 2000-03-22 | Zeneca Ltd | Chemical compounds |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| DE10042059A1 (de) | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
| EP1382603B1 (en) * | 2001-04-26 | 2008-07-23 | Eisai R&D Management Co., Ltd. | Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| JP2005515176A (ja) | 2001-11-03 | 2005-05-26 | アストラゼネカ アクチボラグ | 抗腫瘍剤としてのキナゾリン誘導体 |
| GB0126433D0 (en) | 2001-11-03 | 2002-01-02 | Astrazeneca Ab | Compounds |
| PL371587A1 (en) * | 2002-01-17 | 2005-06-27 | Neurogen Corporation | Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors |
| US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| JP4611745B2 (ja) | 2002-11-20 | 2011-01-12 | アレイ バイオファーマ、インコーポレイテッド | ＥｒｂＢ２及びＥＧＦＲ阻害剤としてのシアノグアニジン及びシアノアミジン |
| GB0309009D0 (en) | 2003-04-22 | 2003-05-28 | Astrazeneca Ab | Quinazoline derivatives |
| GB0326459D0 (en) | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
| MX2008002363A (es) * | 2005-08-17 | 2008-03-18 | Schering Corp | Ligandos novedosos de cinasa basados en quinolina de alta afinidad. |
| CN101490016A (zh) * | 2006-07-28 | 2009-07-22 | 诺瓦提斯公司 | 作为脂激酶抑制剂的2,4-取代的喹唑啉 |
-
2008
- 2008-10-28 NZ NZ585357A patent/NZ585357A/en not_active IP Right Cessation
- 2008-10-28 CN CN200880118458XA patent/CN101878203A/zh active Pending
- 2008-10-28 UA UAA201006435A patent/UA101168C2/ru unknown
- 2008-10-28 AU AU2008320342A patent/AU2008320342B2/en not_active Ceased
- 2008-10-28 MY MYPI2010001916A patent/MY150054A/en unknown
- 2008-10-28 GE GEAP200811821A patent/GEP20125603B/en unknown
- 2008-10-28 US US12/740,527 patent/US8080558B2/en not_active Expired - Fee Related
- 2008-10-28 EP EP08844368A patent/EP2220054A2/en not_active Withdrawn
- 2008-10-28 WO PCT/IN2008/000708 patent/WO2009057139A2/en not_active Ceased
- 2008-10-28 KR KR1020107011577A patent/KR20100087185A/ko not_active Withdrawn
- 2008-10-28 CA CA2703767A patent/CA2703767A1/en not_active Abandoned
- 2008-10-28 EA EA201070543A patent/EA018716B1/ru not_active IP Right Cessation
- 2008-10-28 MX MX2010004625A patent/MX2010004625A/es unknown
- 2008-10-28 JP JP2010531646A patent/JP2011502141A/ja active Pending
-
2010
- 2010-04-21 ZA ZA2010/02807A patent/ZA201002807B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011502141A5 (enExample) | ||
| JP2749458B2 (ja) | アシル化合物 | |
| EP2352723B1 (de) | Pestizide n-aryl- oder n-heteroaryl-pyrazolcarboxamidverbindungen | |
| CN101573344B (zh) | 抗真菌的三唑衍生物、其制备方法以及含有其的药物组合物 | |
| US20070142448A1 (en) | Chromane Substituted Benzimidazole Derivatives | |
| HRP940575A2 (en) | Piperidine derivatives | |
| WO2011082266A2 (en) | Substituted heterocyclic compounds | |
| US8268846B2 (en) | Amino heterocyclic linked pyrimidine derivatives | |
| AU2009245715A1 (en) | Trisubstituted pyrazoles as acetylcholine receptor modulators | |
| TW297813B (enExample) | ||
| CN110392687B (zh) | 稠合的四环或五环二氢二氮杂䓬并咔唑酮的盐的结晶形式及其用途 | |
| US20070066640A1 (en) | Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists | |
| CN102112465A (zh) | 6-[(4s)-2-甲基-4-(2-萘基)-1，2，3，4-四氢异喹啉-7-基]哒嗪-3-胺的晶型 | |
| JP2020507606A (ja) | カルシウムチャネル阻害剤 | |
| CN103717593A (zh) | 调节激酶的组合物和方法 | |
| KR101863708B1 (ko) | 고혈압 및/또는 섬유증 치료용 조성물 | |
| US10407395B2 (en) | Benzimidazole compound and medical use thereof | |
| AU2017200820A1 (en) | Base addition salts of nitroxoline and uses thereof | |
| CA2929563C (en) | Fluorophenyl pyrazol compounds | |
| ES2649403T3 (es) | Nuevas amidas aromáticas insecticidas | |
| JP5323059B2 (ja) | （（フェニル）イミダゾリル）メチルヘテロアリール化合物 | |
| JP7381136B2 (ja) | 高血圧症及び／又は線維症を処置するための組成物 | |
| US8470786B2 (en) | Pyrroloquinolinyl-pyrrolidine-2,5-dione compositions and methods for preparing and using same | |
| CN113527331B (zh) | 硝基咪唑类衍生物及其制备方法和用途 | |
| KR20250158046A (ko) | 시그마-1 수용체 길항제 및 그 응용 |